Diana Ernst

RPh

Most Recent Articles by Diana Ernst

FDA: Lifted Label Defect May Delay Emergency Treatment With Epinephrine

FDA: Lifted Label Defect May Delay Emergency Treatment With Epinephrine

By

The FDA has issued a safety communication alerting patients and healthcare providers that for some EpiPen and EpiPen Jr auto-injectors, and their authorized generics, the device label may become stuck to the inside of the carrier tube and potentially delay administration.

Commonly Prescribed Antihypertensives Linked to Increased Lung Cancer Risk

Commonly Prescribed Antihypertensives Linked to Increased Lung Cancer Risk

By

To investigate the association between this commonly used antihypertensive class and lung cancer, researchers conducted a population based cohort study involving 992,061 patients from the United Kingdom Clinical Practice Research Datalink.

Does Prior Flu Vaccination Affect Subsequent Vaccine Efficacy in Children?

Does Prior Flu Vaccination Affect Subsequent Vaccine Efficacy in Children?

By

To better understand the influence of prior-season vaccination on subsequent influenza vaccine effectiveness, researchers conducted a multiseason, test-negative case-control study among vaccinated children 2-17 years old recruited during 3 influenza seasons (2013-2014, 2014-2015, and 2015-2016).

Trivalent, Quadrivalent Inactivated Influenza Vaccine Approved for Patients 6 Months and Older

Trivalent, Quadrivalent Inactivated Influenza Vaccine Approved for Patients 6 Months and Older

By

The FDA has approved the use of Afluria and Afluria Quadrivalent for use in patients ≥6 months old.

First-in-Class Antiviral Approved for the Treatment of Influenza

First-in-Class Antiviral Approved for the Treatment of Influenza

By

"This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years," said FDA Commissioner Scott Gottlieb, MD.

More Articles by Diana Ernst

Sign Up for Free e-newsletters